_id
69147d64ccc777a4e85d918a
Ticker
MURA
Name
Mural Oncology plc
Exchange
NASDAQ
Address
10 Earlsfort Terrace, Dublin, Ireland, D02 T380
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.muraloncology.com
Description
Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.
Last Close
2.04
Volume
99104
Current Price
2.04
Change
0
Last Updated
2025-12-02T12:15:39.363Z
Image
data:image/webp;base64,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
Ipo Date
2023-11-16T00:00:00.000Z
Market Cap
35209308
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9410000000000001
Sentiment Sources
2
Rating
3.5
Target Price
6
Strong Buy
0
Buy
2
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
3966000
Operating Income
-3966000
Interest Expense
-
Pretax Income
-3706000
Net Income
-3706000
Eps
-0.2139532134086892
Dividends Per Share
-
Shares Outstanding
17344486
Income Tax Expense
-
EBITDA
-2909000
Operating Margin
-
Total Other Income Expense Net
260000
Cash
58871000
Short Term Investments
0
Receivables
-
Inventories
-
Total Current Assets
62158000
Property Plant Equipment
3600000
Total Assets
65758000
Payables
0
Short Term Debt
3505000
Long Term Debt
-
Total Liabilities
10572000
Equity
55186000
Depreciation
800000
Change In Working Capital
-15952000
Cash From Operations
-18481000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-18481000
PE
-
PB
0.6403064139455659
ROE
-6.715471315188634
ROA
-5.635816174457861
FCF
-18481000
Fcf Percent
-
Piotroski FScore
0
Health Score
41
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
7
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
3966000
Quarters > 0 > income Statement > operating Income
-3966000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-3706000
Quarters > 0 > income Statement > net Income
-3706000
Quarters > 0 > income Statement > eps
-0.2139532134086892
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
17321544
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2909000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
260000
Quarters > 0 > balance Sheet > cash
58871000
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
62158000
Quarters > 0 > balance Sheet > property Plant Equipment
3600000
Quarters > 0 > balance Sheet > total Assets
65758000
Quarters > 0 > balance Sheet > payables
0
Quarters > 0 > balance Sheet > short Term Debt
3505000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
10572000
Quarters > 0 > balance Sheet > equity
55186000
Quarters > 0 > cash Flow > net Income
-3706000
Quarters > 0 > cash Flow > depreciation
800000
Quarters > 0 > cash Flow > change In Working Capital
-15952000
Quarters > 0 > cash Flow > cash From Operations
-18481000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-18481000
Quarters > 0 > ratios > PE
-0.2139532134086892
Quarters > 0 > ratios > PB
0.6403064139455659
Quarters > 0 > ratios > ROE
-6.715471315188634
Quarters > 0 > ratios > ROA
-5.635816174457861
Quarters > 0 > ratios > FCF
-18481000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
1100000
Quarters > 1 > income Statement > gross Profit
-1100000
Quarters > 1 > income Statement > operating Expenses
30256000
Quarters > 1 > income Statement > operating Income
-31356000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-47982000
Quarters > 1 > income Statement > net Income
-47982000
Quarters > 1 > income Statement > eps
-2.7780222325150534
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
17272000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-46882000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-16626000
Quarters > 1 > balance Sheet > cash
77094000
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
81556000
Quarters > 1 > balance Sheet > property Plant Equipment
5999000
Quarters > 1 > balance Sheet > total Assets
87555000
Quarters > 1 > balance Sheet > payables
3142000
Quarters > 1 > balance Sheet > short Term Debt
5007000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
28772000
Quarters > 1 > balance Sheet > equity
58783000
Quarters > 1 > cash Flow > net Income
-47982000
Quarters > 1 > cash Flow > depreciation
1140000
Quarters > 1 > cash Flow > change In Working Capital
11077000
Quarters > 1 > cash Flow > cash From Operations
-31363000
Quarters > 1 > cash Flow > capital Expenditures
5000
Quarters > 1 > cash Flow > cash From Investing
1775000
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-29588000
Quarters > 1 > ratios > PE
-2.7780222325150534
Quarters > 1 > ratios > PB
0.5994059507000323
Quarters > 1 > ratios > ROE
-81.62564006600547
Quarters > 1 > ratios > ROA
-54.80212437896179
Quarters > 1 > ratios > FCF
-31368000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
851000
Quarters > 2 > income Statement > gross Profit
-851000
Quarters > 2 > income Statement > operating Expenses
34384000
Quarters > 2 > income Statement > operating Income
-34384000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-33137000
Quarters > 2 > income Statement > net Income
-33137000
Quarters > 2 > income Statement > eps
-1.9300483429436777
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
17169000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-33533000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1247000
Quarters > 2 > balance Sheet > cash
106682000
Quarters > 2 > balance Sheet > short Term Investments
1000000
Quarters > 2 > balance Sheet > receivables
55000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
117651000
Quarters > 2 > balance Sheet > property Plant Equipment
12456000
Quarters > 2 > balance Sheet > total Assets
132079000
Quarters > 2 > balance Sheet > payables
1882000
Quarters > 2 > balance Sheet > short Term Debt
5980000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
24192000
Quarters > 2 > balance Sheet > equity
107887000
Quarters > 2 > cash Flow > net Income
-33137000
Quarters > 2 > cash Flow > depreciation
851000
Quarters > 2 > cash Flow > change In Working Capital
-4929000
Quarters > 2 > cash Flow > cash From Operations
-36798000
Quarters > 2 > cash Flow > capital Expenditures
10000
Quarters > 2 > cash Flow > cash From Investing
27990000
Quarters > 2 > cash Flow > cash From Financing
28000
Quarters > 2 > cash Flow > net Change In Cash
-8780000
Quarters > 2 > ratios > PE
-1.9300483429436777
Quarters > 2 > ratios > PB
0.32464300610824287
Quarters > 2 > ratios > ROE
-30.71454392095433
Quarters > 2 > ratios > ROA
-25.088772628502635
Quarters > 2 > ratios > FCF
-36808000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
3492000
Quarters > 3 > income Statement > cost Of Revenue
1746000
Quarters > 3 > income Statement > gross Profit
-868000
Quarters > 3 > income Statement > operating Expenses
35854000
Quarters > 3 > income Statement > operating Income
-35854000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-34274000
Quarters > 3 > income Statement > net Income
-34274000
Quarters > 3 > income Statement > eps
-2.0079458978269904
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
17069185
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-34986000
Quarters > 3 > income Statement > operating Margin
-1026.7468499427264
Quarters > 3 > income Statement > total Other Income Expense Net
1580000
Quarters > 3 > balance Sheet > cash
115462000
Quarters > 3 > balance Sheet > short Term Investments
28923000
Quarters > 3 > balance Sheet > receivables
51000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
152917000
Quarters > 3 > balance Sheet > property Plant Equipment
14498000
Quarters > 3 > balance Sheet > total Assets
169394000
Quarters > 3 > balance Sheet > payables
2056000
Quarters > 3 > balance Sheet > short Term Debt
5560000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
28892000
Quarters > 3 > balance Sheet > equity
140502000
Quarters > 3 > cash Flow > net Income
-34274000
Quarters > 3 > cash Flow > depreciation
868000
Quarters > 3 > cash Flow > change In Working Capital
591000
Quarters > 3 > cash Flow > cash From Operations
-31770000
Quarters > 3 > cash Flow > capital Expenditures
23000
Quarters > 3 > cash Flow > cash From Investing
36214000
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
4444000
Quarters > 3 > ratios > PE
-2.0079458978269904
Quarters > 3 > ratios > PB
0.24783374898577956
Quarters > 3 > ratios > ROE
-24.393958804856872
Quarters > 3 > ratios > ROA
-20.23330224211011
Quarters > 3 > ratios > FCF
-31793000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-9.104524627720505
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
3512000
Annuals > 0 > income Statement > gross Profit
-3512000
Annuals > 0 > income Statement > operating Expenses
134750000
Annuals > 0 > income Statement > operating Income
-138262000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-128514000
Annuals > 0 > income Statement > net Income
-128514000
Annuals > 0 > income Statement > eps
-7.579710999705101
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
16955000
Annuals > 0 > income Statement > income Tax Expense
-128514000
Annuals > 0 > income Statement > EBITDA
-125002000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
9748000
Annuals > 0 > balance Sheet > cash
115462000
Annuals > 0 > balance Sheet > short Term Investments
28923000
Annuals > 0 > balance Sheet > receivables
51000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
152917000
Annuals > 0 > balance Sheet > property Plant Equipment
14498000
Annuals > 0 > balance Sheet > total Assets
169394000
Annuals > 0 > balance Sheet > payables
2056000
Annuals > 0 > balance Sheet > short Term Debt
5560000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
28892000
Annuals > 0 > balance Sheet > equity
140502000
Annuals > 0 > cash Flow > net Income
-128514000
Annuals > 0 > cash Flow > depreciation
3512000
Annuals > 0 > cash Flow > change In Working Capital
-6046000
Annuals > 0 > cash Flow > cash From Operations
-128545000
Annuals > 0 > cash Flow > capital Expenditures
92000
Annuals > 0 > cash Flow > cash From Investing
-25330000
Annuals > 0 > cash Flow > cash From Financing
196000
Annuals > 0 > cash Flow > net Change In Cash
-153679000
Annuals > 0 > ratios > PE
-7.579710999705101
Annuals > 0 > ratios > PB
0.24496911075998917
Annuals > 0 > ratios > ROE
-91.46773711406243
Annuals > 0 > ratios > ROA
-75.8669138222133
Annuals > 0 > ratios > FCF
-128637000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
2567000
Annuals > 1 > income Statement > gross Profit
-2567000
Annuals > 1 > income Statement > operating Expenses
192071000
Annuals > 1 > income Statement > operating Income
-194638000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-195287000
Annuals > 1 > income Statement > net Income
-207447000
Annuals > 1 > income Statement > eps
-12.42961244453179
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
16689740
Annuals > 1 > income Statement > income Tax Expense
12160000
Annuals > 1 > income Statement > EBITDA
-192720000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-649000
Annuals > 1 > balance Sheet > cash
270852000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
5548000
Annuals > 1 > balance Sheet > inventories
150000
Annuals > 1 > balance Sheet > total Current Assets
277337000
Annuals > 1 > balance Sheet > property Plant Equipment
24150000
Annuals > 1 > balance Sheet > total Assets
301745000
Annuals > 1 > balance Sheet > payables
5973000
Annuals > 1 > balance Sheet > short Term Debt
6098000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
37928000
Annuals > 1 > balance Sheet > equity
263817000
Annuals > 1 > cash Flow > net Income
-207447000
Annuals > 1 > cash Flow > depreciation
2567000
Annuals > 1 > cash Flow > change In Working Capital
-13478000
Annuals > 1 > cash Flow > cash From Operations
-194249000
Annuals > 1 > cash Flow > capital Expenditures
3452000
Annuals > 1 > cash Flow > cash From Investing
-3452000
Annuals > 1 > cash Flow > cash From Financing
468811000
Annuals > 1 > cash Flow > net Change In Cash
271110000
Annuals > 1 > ratios > PE
-12.42961244453179
Annuals > 1 > ratios > PB
0.12842300609892462
Annuals > 1 > ratios > ROE
-78.63291599858994
Annuals > 1 > ratios > ROA
-68.74910934729655
Annuals > 1 > ratios > FCF
-197701000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1540000
Annuals > 2 > income Statement > gross Profit
-1540000
Annuals > 2 > income Statement > operating Expenses
184923000
Annuals > 2 > income Statement > operating Income
-184923000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-184923000
Annuals > 2 > income Statement > net Income
-189807000
Annuals > 2 > income Statement > eps
-11.373774218414432
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
16688128
Annuals > 2 > income Statement > income Tax Expense
4884000
Annuals > 2 > income Statement > EBITDA
-183383000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
10223000
Annuals > 2 > balance Sheet > cash
-19386000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
4817000
Annuals > 2 > balance Sheet > property Plant Equipment
28933000
Annuals > 2 > balance Sheet > total Assets
33750000
Annuals > 2 > balance Sheet > payables
2966000
Annuals > 2 > balance Sheet > short Term Debt
5844000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
55406000
Annuals > 2 > balance Sheet > equity
-21656000
Annuals > 2 > cash Flow > net Income
-189807000
Annuals > 2 > cash Flow > depreciation
1540000
Annuals > 2 > cash Flow > change In Working Capital
7748000
Annuals > 2 > cash Flow > cash From Operations
-168588000
Annuals > 2 > cash Flow > capital Expenditures
5511000
Annuals > 2 > cash Flow > cash From Investing
-5511000
Annuals > 2 > cash Flow > cash From Financing
174099000
Annuals > 2 > cash Flow > net Change In Cash
0
Annuals > 2 > ratios > PE
-11.373774218414432
Annuals > 2 > ratios > PB
-1.5643193498337642
Annuals > 2 > ratios > ROE
876.4637975618766
Annuals > 2 > ratios > ROA
-562.3911111111111
Annuals > 2 > ratios > FCF
-174099000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1474000
Annuals > 3 > income Statement > gross Profit
-1474000
Annuals > 3 > income Statement > operating Expenses
173891000
Annuals > 3 > income Statement > operating Income
-175365000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-175365000
Annuals > 3 > income Statement > net Income
-175433000
Annuals > 3 > income Statement > eps
-10.512443336963859
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
16688128
Annuals > 3 > income Statement > income Tax Expense
68000
Annuals > 3 > income Statement > EBITDA
-173891000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > balance Sheet > cash
-25306000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
4239000
Annuals > 3 > balance Sheet > property Plant Equipment
30871000
Annuals > 3 > balance Sheet > total Assets
35110000
Annuals > 3 > balance Sheet > payables
10586000
Annuals > 3 > balance Sheet > short Term Debt
5920000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
52989000
Annuals > 3 > balance Sheet > equity
-17879000
Annuals > 3 > cash Flow > net Income
-175433000
Annuals > 3 > cash Flow > depreciation
1474000
Annuals > 3 > cash Flow > change In Working Capital
5787000
Annuals > 3 > cash Flow > cash From Operations
-156668000
Annuals > 3 > cash Flow > capital Expenditures
4385000
Annuals > 3 > cash Flow > cash From Investing
-4385000
Annuals > 3 > cash Flow > cash From Financing
161053000
Annuals > 3 > cash Flow > net Change In Cash
0
Annuals > 3 > ratios > PE
-10.512443336963859
Annuals > 3 > ratios > PB
-1.8947871715420324
Annuals > 3 > ratios > ROE
981.223782090721
Annuals > 3 > ratios > ROA
-499.66676160637996
Annuals > 3 > ratios > FCF
-161053000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.2139532134086892
Valuation > metrics > PB
0.6403064139455659
Valuation > final Score
70
Valuation > verdict
36.0% Undervalued
Profitability > metrics > ROE
-6.715471315188634
Profitability > metrics > ROA
-5.962225296824222
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.19157032580726996
Risk > metrics > Interest Coverage
-4.976160602258469
Risk > final Score
40
Risk > verdict
High
Liquidity > metrics > Current Ratio
17.734094151212553
Liquidity > metrics > Quick Ratio
17.734094151212553
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-54
Prev Risks > 1
-287
Prev Risks > 2
-141
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:15:04.940Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-31
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.37
Earnings History > 0 > eps Difference
0.37
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.21
Earnings History > 1 > eps Estimate
-0.3
Earnings History > 1 > eps Difference
0.09
Earnings History > 1 > surprise Percent
30
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-04
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-2.78
Earnings History > 2 > eps Estimate
-1.1
Earnings History > 2 > eps Difference
-1.68
Earnings History > 2 > surprise Percent
-152.7273
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-20
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-1.93
Earnings History > 3 > eps Estimate
-1.98
Earnings History > 3 > eps Difference
0.05
Earnings History > 3 > surprise Percent
2.5253
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-11
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-2.01
Earnings History > 4 > eps Estimate
-1.99
Earnings History > 4 > eps Difference
-0.02
Earnings History > 4 > surprise Percent
-1.005
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-13
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.87
Earnings History > 5 > eps Estimate
-1.97
Earnings History > 5 > eps Difference
0.1
Earnings History > 5 > surprise Percent
5.0761
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-13
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.86
Earnings History > 6 > eps Estimate
-1.95
Earnings History > 6 > eps Difference
0.09
Earnings History > 6 > surprise Percent
4.6154
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-14
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-1.84
Earnings History > 7 > eps Estimate
-2.66
Earnings History > 7 > eps Difference
0.82
Earnings History > 7 > surprise Percent
30.8271
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-26
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-3.5673
Earnings History > 8 > eps Estimate
-3.57
Earnings History > 8 > eps Difference
0.0027
Earnings History > 8 > surprise Percent
0.0756
Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShareholder Notice: M&A Class Action Firm Ongoing Investigation into Merger Involving GTLS, PHLT, ARIS, and MURA Intellectia AI
Read more →Chart Watch: Can NMFC lead its sector in growth - Oil Prices & Weekly Watchlist for Hot Stocks baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$6
Analyst Picks
Strong Buy
0
Buy
2
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Mural Oncology plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.37
Date
2025-09-30
EPS Actual
-0.21
EPS Estimate
-0.3
EPS Difference
0.09
Surprise Percent
30%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.